Propanc Biopharma enters $150K AUD loan agreement with 12% interest, due Nov 2024

Propanc Biopharma, Inc.

Loan of $150,000 AUD effective Aug 1, 2024, with maturity Nov 1, 2024.
Interest rate 12% per annum; prepayable at any time without penalty.
Proceeds will be used for general working capital purposes.
Loan issued under private placement exemption per Section 4(a)(2) and Rule 506.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.